有没有任何强有力的证据表明SGLT2抑制剂会导致癌症的发生?
Sidar Copur1, Abdullah B Yildiz1, Adrian Covic2
1Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
European journal of clinical investigation
|November 27, 2023
概括
-葡萄糖共运输体2 (SGLT-2) 抑制剂通过各种机制显示出潜在的抗癌作用. 需要进一步的研究来证实它们在癌症治疗中的预防和治疗作用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
背景情况:
- 用于治疗II型糖尿病的-葡萄糖共运输体2 (SGLT-2) 抑制剂正在研究其潜在的抗癌性质.
- 机制包括ATP生产的抑制,AMPK信号传递,细胞亡,铁亡和DNA/RNA合成.
研究的目的:
- 审查SGLT-2抑制剂的潜在抗癌作用.
- 探索潜在的机制,临床前和临床数据以及未来的前景.
主要方法:
- 现有文献的叙述性审查.
- 讨论临床前研究,临床试验和流行病学数据.
主要成果:
- SGLT-2 抑制剂可能具有抗增殖作用,但临床前发现有所不同.
- 分析显示,除了empagliflozin和膀癌外,整体恶性瘤没有显著增加.
- 有潜力减少化疗引起的心脏毒性,增强抗癌效果.
结论:
- 需要更多的大规模研究来验证SGLT-2抑制剂在癌症中的预防和治疗潜力.
- SGLT-2 抑制剂可能为癌症治疗和管理提供新的策略.
关键词:
SGLT2 抑制剂的使用.可以使用Canagliflozin.癌症 癌症 癌症 癌症 癌症达帕格利弗洛辛 (Dapagliflozin) 是一种艾姆帕格利夫洛辛 (Empagliflozin) 是一种膀癌是尿道癌症的一种.更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.8K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Glucose Transporters
22.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
